![]() |
市场调查报告书
商品编码
1433325
全球血液处理设备及耗材市场 2023-2030Global Blood Processing Devices and Consumables Market 2023-2030 |
由于需要输血的疾病负担增加、外科手术增加以及老年人口增加,预计全球血液处理设备和耗材市场在预测期内(2023-2030年)将以9.2%的CAGR增长。手术或其他输血程序对安全血液供应的需求不断增长表明了市场的成长。为了克服因输血和捐血引起的感染,使用了多台血液处理机和血液处理耗材来预防感染。
全球血液处理设备和耗材市场按血液处理设备和耗材细分。根据血液处理设备,市场细分为血库冷冻机、血液加温器、血型分析仪、血库冰箱、血球容积比离心机和血球处理器。此外,根据消耗品,市场细分为采血针、小瓶、显微镜载玻片、血袋、输血套件等。在消耗品中,由于医院、血库和其他医疗中心数量的增加,血袋细分市场预计将占据相当大的市场份额。此外,公民捐血意识的增强也推动了全球对血袋的需求。
在血液处理设备中,血球处理器子细分市场预计将在全球血液处理设备和耗材市场中占据相当大的份额。血球处理器是输血医学领域宝贵的救生程序之一。血球处理器采用基于离心机的技术将全血分离为其主要成分。血球处理器为分离细胞产品的劳动密集型技术提供了一种选择,例如使用锥形管在密度梯度分离介质上手动分层血液。血球处理器用于血库、输血实验室、细胞治疗实验室和製造设施。捐血数量的增加以及市场参与者推出新产品是推动该领域成长的主要因素。据世界卫生组织称,全球每年收集约1.185亿单位的捐献血液,但还需要收集更多单位才能满足全球所有患者的输血需求。据报道,2008 年至 2018 年,自愿无偿捐血者的捐血量增加了 1,070 万次。
全球血液处理设备和耗材市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲。其中,亚太地区预计将在全球市场中占据显着份额,由于医疗保健支出的增加以及中国和印度等国家改善医疗保健基础设施的倡议推动了先进血液处理技术和耗材的采用。
在所有地区中,由于血癌病例的增加以及多个从事血液成分分配的组织的存在而产生了血液处理的需求,预计北美地区在预测期内将以相当大的CAGR增长。骨髓、血球、淋巴结和其他淋巴系统组成部分都可能受到白血病、淋巴瘤、骨髓瘤和骨髓增生异常综合症 (MDS) 等癌症的影响。显然,单采技术已被用来降低白血球计数,直到其他药物能够调节它。
根据白血病和淋巴瘤协会 (LLS) 的数据,到 2021 年,美国大约每三分钟就有一人被诊断出患有血癌。大约每 9 分钟,美国就有一人死于血癌。此外,该地区的组织致力于提高公民的捐血意识,也推动了对血液处理设备和耗材市场的需求。据估计,美国每年有 680 万人捐血,每年收集 1,360 万单位的全血和红血球。
Global Blood Processing Devices and Consumables Market Size, Share & Trends Analysis Report by Blood Processing Devices (Blood Bank Freezers, Blood Warmers, Blood Grouping Analyzers, Blood Bank Refrigerators, Hematocrit Centrifuges and Blood Cell Processors), and by Consumables (Blood Lancets, Vials, Microscopic Slides, Blood Bags, Blood Administration Sets, and Others), Forecast Period (2023-2030)
The global blood processing devices and consumables market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030) owing to the rise burden of disorders requiring blood transfusion, increasing surgical procedures, as well as increasing geriatric population. The rising need for safe blood supply for surgeries or other transfusion procedures is shows market growth. To overcome the infections caused due to blood transfusions and blood donation, several blood processing machines and blood processing consumables are utilized to prevent infection.
The global blood processing devices and consumables market is segmented by the blood processing devices, and consumables. Based on the blood processing devices, the market is sub-segmented into blood bank freezers, blood warmers, blood grouping analyzers, blood bank refrigerators, hematocrit centrifuges and blood cell processors. Further, based on consumables, the market is sub-segmented into blood lancets, vials, microscopic slides, blood bags, blood administration sets, and others. Among the consumables, the blood bags sub-segment is anticipated to hold a considerable share of the market due to rising numbers of hospitals, blood banks, and other healthcare centers. Furthermore, the growing awareness about blood donation among citizens is also propelling the demand for blood bags, globally.
Among the blood processing devices, the blood cell processors sub-segment is expected to hold a considerable share of the global Blood Processing Devices and Consumables market. Blood cell processors is one of the precious lifesaving procedures in the field of transfusion medicine. Blood cell processors employs centrifuge-based technology to separate the whole blood into its major components. Blood cell processors provide an option to labor-intensive techniques for separating cell products, such as manually layering blood over a density gradient separation medium using conical tubes. Blood cell processors are used in blood banks, transfusion laboratories, cellular therapy laboratories, and manufacturing facilities. Increasing number of blood donations as well as the introduction of new products by the market players are major factors fueling the growth of the segment. According to WHO, around 118.5 million units of donated blood are collected globally every year, although more units would need to be collected to meet the needs of transfusion of all the patients in the globally. An increase of 10.7 million blood donations from voluntary unpaid donors has been reported from 2008 to 2018.
The global blood processing devices and consumables market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increasing healthcare expenditure and government initiatives to improve healthcare infrastructure in countries such as China and India drive the adoption of advanced blood processing technologies and consumables.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period due to the rising cases blood cancer and presence of several organizations engaged in the distribution of blood components that arises the need for blood processing. Bone marrow, blood cells, lymph nodes, and other lymphatic system components can all be impacted by cancers such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS). Apheresis technology has apparently been utilized to lower the white cell count until other drugs are able to regulate it.
According to the Leukemia and Lymphoma Society (LLS), approximately every three minutes, one person in the US is diagnosed with blood cancer in 2021. Approximately every 9 minutes, someone in the US dies from a blood cancer. Moreover, organizations in the region are engaged in growing awareness about blood donation among citizens is also propelling the demand for blood processing devices and consumables market. Each year, an estimated 6.8 million people in the U.S. donate blood and 13.6 million units of whole blood and red blood cells are collected in the U.S. in a year.
The major companies serving the global blood processing devices and consumables market include Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021, BD (Becton, Dickinson and Company), acquired Velano Vascular. The Velano Vascular acquisition is in line with BD's growth strategy to enter new categories that deal with unmet needs and have a more positive impact on patients and health systems. Velano Vascular offers an innovative, needle-free technology that enables high-quality blood drawn from existing peripheral intravenous catheter (PIVC) lines, BD can now enable health care providers to help eliminate multiple needlesticks for blood sample collection, reducing the pain and discomfort from the process while delivering quality outcomes